RNS Number : 3625WAlliance Pharma PLC17 August 2022

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0031030819

Issuer Name

ALLIANCE PHARMA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Royal Bank of Canada PH

City of registered office (if applicable)

Country of registered office (if applicable)

CA

4. Details of the shareholder

Name

City of registered office

Country of registered office

RBC Global Asset Management (UK) Limited

London

England

5. Date on which the threshold was crossed or reached

08-Jun-2022

6. Date on which Issuer notified

10-Jun-2022

7. Total positions of person(s) subject to the notification obligation

.

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.067000

0.000000

3.067000

16546166

Position of previous notification (if applicable)

2.999000

0.000000

2.999000


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0031030819

16546166


3.067000


Sub Total 8.A

16546166

3.067000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights





Sub Total 8.B1




8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights






Sub Total 8.B2




9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Royal Bank of Canada

Royal Bank of Canada Holdings (U.K.) Limited

3.067000


3.067000%

Royal Bank of Canada

RBC Global Asset Management (UK) Limited

3.067000


3.067000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

10-Jun-2022

13. Place Of Completion

Toronto, Canada

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDHOLEAAPXFAEAEFA


The service was requested through Alliance Pharma PLC. To modify your subscription, please subscribe again. If you no longer wish to receive these emails, you may unsubscribe at any time.
Supplied